- The FDA has not identified a stroke risk in seniors who received the Pfizer booster after reviewing multiple federal databases.
- The FDA also reached out to regulators in Europe and Israel, who did not report an increased risk of stroke.
- Preliminary CDC data indicated a possible stroke risk following simultaneous administration of the Pfizer Covid booster and the flu vaccine.
- FDA is launching a study to look into this possibility.
Disclaimer: This story is generated from RSS Feed and has not been created or edited by Waba News. Publisher: CNBC